JP Stock MarketDetailed Quotes

4883 Modalis Therapeutics

Watchlist
  • 102
  • +2+2.00%
20min DelayMarket Closed Dec 23 15:30 JST
7.08BMarket Cap-1.32P/E (Static)

Modalis Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2023
(FY)Dec 31, 2022
(FY)Dec 31, 2021
(FY)Dec 31, 2020
(FY)Dec 31, 2019
(FY)Dec 31, 2018
Operating cash flow (Indirect Method)
Cash from operating activities
-19.08%-2.25B
-53.24%-1.89B
-227.98%-1.23B
-265.19%-375.76M
207.32%227.47M
-211.95M
Net profit before non-cash adjustment
11.69%-2.39B
-263.16%-2.71B
-69.59%-745.42M
-400.34%-439.55M
168.58%146.35M
---213.39M
Total adjustment of non-cash items
-87.05%101.8M
250.66%786.03M
-633.42%-521.71M
209.72%97.81M
407.49%31.58M
---10.27M
-Depreciation and amortization
-99.41%731K
58.82%123.68M
35.22%77.87M
760.42%57.59M
1,501.20%6.69M
--418K
-Reversal of impairment losses recognized in profit and loss
-96.11%38.82M
--996.8M
--0
----
----
----
-Disposal profit
--0
-73.68%552K
--2.1M
--0
----
----
-Net exchange gains and losses
46.95%-27.86M
-347.79%-52.52M
-445.68%-11.73M
--3.39M
----
----
-Remuneration paid in stock
-10.22%9.64M
86.29%10.74M
--5.76M
--0
----
----
-Other non-cash items
127.45%80.47M
50.78%-293.21M
-1,717.72%-595.71M
47.97%36.82M
332.84%24.89M
---10.69M
Changes in working capital
22.86%39.94M
-6.39%32.51M
202.08%34.72M
-168.66%-34.02M
323.11%49.54M
--11.71M
-Change in receivables
-142.25%-9.56M
232.08%22.62M
-603.08%-17.13M
-101.32%-2.44M
-126.25%-1.21M
--4.61M
-Change in payables
-202.98%-22.36M
-51.99%21.71M
227.30%45.22M
-175.75%-35.52M
6,770.13%46.89M
---703K
-Change in accrued expense
707.54%71.85M
-278.34%-11.83M
68.21%6.63M
2.20%3.94M
-50.56%3.86M
--7.8M
Dividends paid (cash flow from operating activities)
Dividends received (cash flow from operating activities)
Interest paid (cash flow from operating activities)
27.97%-4.41M
-6.13M
0
Interest received (cash flow from operating activities)
-56.14%25K
0.00%57K
9.62%57K
160.00%52K
100.00%20K
10K
Tax refund paid
0.00%-1.21M
0.00%-1.21M
-27.37%-1.21M
75.12%-950K
-165.02%-3.82M
-1.44M
Other operating cash inflow (outflow)
0
0
615,200.00%486.09M
-83.47%79K
-38.24%478K
774K
Operating cash flow
-18.92%-2.25B
-153.63%-1.9B
-98.49%-747.47M
-268.00%-376.58M
205.43%224.15M
---212.61M
Investing cash flow
Net PPE purchase and sale
79.88%-39.7M
-84.19%-197.29M
-607.10%-107.11M
72.09%-15.15M
-9,805.84%-54.28M
---548K
Net intangibles purchase and sale
----
----
140.46%329.67M
---814.87M
----
----
Net changes in other investments
----
122.68%11.57M
-17,128.38%-51M
96.05%-296K
-16.08%-7.49M
---6.45M
Investing cash flow
78.62%-39.7M
-208.25%-185.72M
120.66%171.56M
-1,244.22%-830.31M
-782.92%-61.77M
---7M
Financing cash flow
Net issuance payments of debt
--488.46M
--0
----
----
----
----
Net common stock issuance
1,108.63%736.12M
-16.15%60.91M
-97.40%72.63M
12.34%2.8B
--2.49B
----
Issuance fees
----
----
----
---20.1M
----
----
Net other fund-raising expenses
-392.66%-8.13M
277,900.00%2.78M
99.41%-1K
20.28%-169K
15.20%-212K
---250K
Financing cash flow
1,810.17%1.22B
-12.32%63.68M
-97.39%72.63M
11.54%2.78B
996,341.20%2.49B
---250K
Net cash flow
Beginning cash position
-40.58%2.93B
-8.95%4.94B
40.55%5.42B
220.06%3.86B
-15.42%1.21B
--1.42B
Current changes in cash
46.59%-1.08B
-300.94%-2.02B
-132.03%-503.27M
-40.78%1.57B
1,306.70%2.65B
---219.85M
Effect of exchange rate changes
89.40%27.99M
-17.84%14.78M
362.01%17.99M
-671.35%-6.87M
-749.64%-890K
--137K
Cash adjustments other than cash changes
----
----
----
---1K
----
---1K
End cash Position
-35.79%1.88B
-40.58%2.93B
-8.95%4.94B
40.55%5.42B
220.06%3.86B
--1.21B
Free cash flow
-9.61%-2.29B
-144.92%-2.09B
29.17%-854.58M
-810.33%-1.21B
179.69%169.86M
---213.16M
Currency Unit
JPY
JPY
JPY
JPY
JPY
JPY
Accounting Standards
NonUS-GAAP
NonUS-GAAP
NonUS-GAAP
NonUS-GAAP
NonUS-GAAP
NonUS-GAAP
(FY)Dec 31, 2023(FY)Dec 31, 2022(FY)Dec 31, 2021(FY)Dec 31, 2020(FY)Dec 31, 2019(FY)Dec 31, 2018
Operating cash flow (Indirect Method)
Cash from operating activities -19.08%-2.25B-53.24%-1.89B-227.98%-1.23B-265.19%-375.76M207.32%227.47M-211.95M
Net profit before non-cash adjustment 11.69%-2.39B-263.16%-2.71B-69.59%-745.42M-400.34%-439.55M168.58%146.35M---213.39M
Total adjustment of non-cash items -87.05%101.8M250.66%786.03M-633.42%-521.71M209.72%97.81M407.49%31.58M---10.27M
-Depreciation and amortization -99.41%731K58.82%123.68M35.22%77.87M760.42%57.59M1,501.20%6.69M--418K
-Reversal of impairment losses recognized in profit and loss -96.11%38.82M--996.8M--0------------
-Disposal profit --0-73.68%552K--2.1M--0--------
-Net exchange gains and losses 46.95%-27.86M-347.79%-52.52M-445.68%-11.73M--3.39M--------
-Remuneration paid in stock -10.22%9.64M86.29%10.74M--5.76M--0--------
-Other non-cash items 127.45%80.47M50.78%-293.21M-1,717.72%-595.71M47.97%36.82M332.84%24.89M---10.69M
Changes in working capital 22.86%39.94M-6.39%32.51M202.08%34.72M-168.66%-34.02M323.11%49.54M--11.71M
-Change in receivables -142.25%-9.56M232.08%22.62M-603.08%-17.13M-101.32%-2.44M-126.25%-1.21M--4.61M
-Change in payables -202.98%-22.36M-51.99%21.71M227.30%45.22M-175.75%-35.52M6,770.13%46.89M---703K
-Change in accrued expense 707.54%71.85M-278.34%-11.83M68.21%6.63M2.20%3.94M-50.56%3.86M--7.8M
Dividends paid (cash flow from operating activities)
Dividends received (cash flow from operating activities)
Interest paid (cash flow from operating activities) 27.97%-4.41M-6.13M0
Interest received (cash flow from operating activities) -56.14%25K0.00%57K9.62%57K160.00%52K100.00%20K10K
Tax refund paid 0.00%-1.21M0.00%-1.21M-27.37%-1.21M75.12%-950K-165.02%-3.82M-1.44M
Other operating cash inflow (outflow) 00615,200.00%486.09M-83.47%79K-38.24%478K774K
Operating cash flow -18.92%-2.25B-153.63%-1.9B-98.49%-747.47M-268.00%-376.58M205.43%224.15M---212.61M
Investing cash flow
Net PPE purchase and sale 79.88%-39.7M-84.19%-197.29M-607.10%-107.11M72.09%-15.15M-9,805.84%-54.28M---548K
Net intangibles purchase and sale --------140.46%329.67M---814.87M--------
Net changes in other investments ----122.68%11.57M-17,128.38%-51M96.05%-296K-16.08%-7.49M---6.45M
Investing cash flow 78.62%-39.7M-208.25%-185.72M120.66%171.56M-1,244.22%-830.31M-782.92%-61.77M---7M
Financing cash flow
Net issuance payments of debt --488.46M--0----------------
Net common stock issuance 1,108.63%736.12M-16.15%60.91M-97.40%72.63M12.34%2.8B--2.49B----
Issuance fees ---------------20.1M--------
Net other fund-raising expenses -392.66%-8.13M277,900.00%2.78M99.41%-1K20.28%-169K15.20%-212K---250K
Financing cash flow 1,810.17%1.22B-12.32%63.68M-97.39%72.63M11.54%2.78B996,341.20%2.49B---250K
Net cash flow
Beginning cash position -40.58%2.93B-8.95%4.94B40.55%5.42B220.06%3.86B-15.42%1.21B--1.42B
Current changes in cash 46.59%-1.08B-300.94%-2.02B-132.03%-503.27M-40.78%1.57B1,306.70%2.65B---219.85M
Effect of exchange rate changes 89.40%27.99M-17.84%14.78M362.01%17.99M-671.35%-6.87M-749.64%-890K--137K
Cash adjustments other than cash changes ---------------1K-------1K
End cash Position -35.79%1.88B-40.58%2.93B-8.95%4.94B40.55%5.42B220.06%3.86B--1.21B
Free cash flow -9.61%-2.29B-144.92%-2.09B29.17%-854.58M-810.33%-1.21B179.69%169.86M---213.16M
Currency Unit JPYJPYJPYJPYJPYJPY
Accounting Standards NonUS-GAAPNonUS-GAAPNonUS-GAAPNonUS-GAAPNonUS-GAAPNonUS-GAAP
Top JP Stock Gainers
Symbol Price % Chg
FunPep
4881
172 +35.43%
Liberta
4935
2800 +21.74%
True Data
4416
930 +19.23%
AR Advanced Technology
5578
1805 +19.14%
Leoclan
7681
1019 +17.26%

See the daily top gainer.